1-3 of 3
Federica Melle
Close
Sort by
Journal Articles

Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL

Saveria Mazzara, Laura Travaini, Francesca Botta, Chiara Granata, Giovanna Motta, Federica Melle, Stefano Fiori, Valentina Tabanelli, Anna Vanazzi, Safaa Ramadan, Tommaso Radice, Sara Raimondi, Giuliana Lo Presti, Mahila E. Ferrari, Barbara Alicja Jereczek-Fossa, Corrado Tarella, Francesco Ceci, Stefano Pileri, Enrico Derenzini
Journal: Blood Advances
Blood Adv (2023) 7 (4): 630–643.
https://doi.org/10.1182/bloodadvances.2022007825
Published: 2023
Includes: Supplemental data
Journal Articles

The identification of TCF1 + progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade

Valentina Tabanelli, Federica Melle, Giovanna Motta, Saveria Mazzara, Marco Fabbri, Claudio Agostinelli, Angelica Calleri, Marcello Del Corvo, Stefano Fiori, Daniele Lorenzini, Alessandra Cesano, Annalisa Chiappella, Umberto Vitolo, Enrico Derenzini, Gabriel K. Griffin, Scott J. Rodig, Anna Vanazzi, Elena Sabattini, Corrado Tarella, Maria Rosaria Sapienza, Stefano A. Pileri
Journal: Blood Advances
Blood Adv (2022) 6 (15): 4634–4644.
https://doi.org/10.1182/bloodadvances.2022007046
Published: 2022
Includes: Supplemental data
Journal Articles

Antitumor activity of the dual BET and CBP/EP300 inhibitor NEO2734

Filippo Spriano, Eugenio Gaudio, Luciano Cascione, Chiara Tarantelli, Federica Melle, Giovanna Motta, Valdemar Priebe, Andrea Rinaldi, Gaetanina Golino, Afua Adjeiwaa Mensah, Luca Aresu, Emanuele Zucca, Stefano Pileri, Michael Witcher, Bill Brown, Claes Wahlestedt, Francis Giles, Anastasios Stathis, Francesco Bertoni
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4124–4135.
https://doi.org/10.1182/bloodadvances.2020001879
Published: 2020
Includes: Supplemental data